Tiffany Chen, Rachana Gudipudi, Shaun A Nguyen, William Carroll, Clarice Clemmens
BACKGROUND: Although propranolol has been established as the gold standard when treatment is sought for infantile hemangioma, concerns over its side effect profile have led to increasing usage of atenolol, a beta-1 selective blocker. METHODS: A systematic review of PubMed, Scopus, CINAHL, Google Scholar, and Cochrane was conducted following PRISMA guidelines using MeSH terms and keywords for the terms propranolol, atenolol, and infantile hemangioma, including alternative spellings...
April 25, 2022: Annals of Otology, Rhinology, and Laryngology